Outcomes in Patients with Testicular Maldescent and Germ Cell Neoplasia: A Retrospective Assessment and Review of the Literature

Crossmark: check for updates

Authors

  • Jeffrey A. Jones Baylor College of Medicine, Houston, Texas, USA
  • Christopher W. Hobaugh Baylor College of Medicine, Houston, Texas, USA
  • Daniel B. Salvas Indiana University Medical Center, Indianapolis, IN, USA
  • Richard M. Bennett Indiana University Medical Center, Indianapolis, IN, USA
  • Guilherme Godoy Baylor College of Medicine, Houston, Texas, USA
  • John P. Donohue Indiana University Medical Center, Indianapolis, IN, USA

DOI:

https://doi.org/10.17140/UAOJ-2-113

Keywords:

Testes cancer, Germ cell tumor, Undescended testes, Maldescent, Cryptorchidism, Orchidopexy, Retroperitoneal lymph node dissection

Abstract

Introduction
Cryptorchidism is not an uncommon problem in young males, yet the ideal management of the undescended testes (UDT) is not clear-cut. Multiple issues influence the patient-physician decision process regarding treatment including fertility, hormone-production, cosmesis and the risk of testicular germ cell tumors (TGCT's).
Methods
A retrospective review of 2204 men presenting to Indiana University Medical Center or Baylor College of Medicine affiliated hospitals with TGCT during a 20 year period was conducted, and individuals with a history of UDT were identified. Clinical outcomes of the 94 men with UDT and TGCT who did, and did not, undergo orchidopexy were compared. Statistical analysis included chi-square, Fischer’s exact test and confidence intervals.
Results
Of the 94 patients identified with UDT and TGCT, 87 had a complete evaluable dataset. Fifty-two patients out of the 87 had tumors ipsilateral to the UDT (in the previously undescended testicle). Forty-nine of the 52 patients with UDT (94%) were corrected by orchidopexy at ages ranging from one to twenty six. Of the 49 orchidopexies in the ipsilateral tumor group, 48 (98%) were successful and 1 failed. Two patients had spontaneous testicular descent and 2 patients had descent with hormonal therapy. Ten patients had no treatment. The average interval from the time of UDT diagnosis and the development of GCT ipsilateral to the previously UDT was 18 years. Twenty-four patients had tumors contralateral to the UDT. 54.1%(13/24) with tumors developing in the contralateral testes had successful orchidopexy at an average age of 7 years. Of the remaining 11 of 24, four patients had contralateral orchiectomy at the time of treatment of the UDT. Exploration was conducted and no tissue identified in 3. Two patients had spontaneous descent. Two patients had no treatment. The average time interval from diagnosis of UDT to the diagnosis of GCT was 22 years. A much greater percentage of patients developed tumors in the previously undescended testicle if the orchidopexy was performed after the age of 10 years. Performing orchidopexy prior to the age of 5 years, however, did not protect the testes from the development of cancer. There is no statistical difference between the groups with ipsilateral and contralateral tumors with respect to age at tumor presentation or the time interval from orchidopexy to tumor diagnosis. Sixty-three percent of patients with tumors developing in untreated testes or testes suffering from failed orchidopexies, presented with advanced disease (B3 or C), compared with 43% of patients with treated UDT’s and 34% of patients with tumors developing in descended testes contralateral to UDT’s, an odds ratio of 2.39, but not statistically significant. The mortality for patients who had untreated or failed orchidopexies, 27%(3/11) was 4.5 times higher than those with successful orchidopexies 8% (4/52), p=0.06 at 95% confidence limit, or 3.3 times higher than for patients with normally descended testes.

Conclusion

Germ cell tumors occurred on average 7-10 years earlier in patients with UDT ipsilateral to the side of TGCT than in those where GCT developed in the contralateral normally descended testes. Orchidopexy did not confer protection to testes in the development of TGCTs, however, there was a non-significant delay in the time to onset of tumor and the percentage of the advance stage at presentation compared to untreated testes or normally descended testes. In this series, early orchidopexy was associated with 4.5 less likelihood of dying from GCT compared with non-treated testes, a difference which approached, but did not reach, statistical significance.

References

Levin A, Sherman JO. The undescended testis. Surgery Gynecol Obstet. 1979; 136: 473-479.

Mostofi FK. Testicular tumors. Cancer. 1973; 32: 1186-1201.

Giwercman A, Muller J, Skakkebaek NE. Cryptorchidism and testicular Neoplasia. Horm Res. 1988; 30: 157-163. doi: 10.1159/000181053

Ford TF, Parkinson MC, Pryor JP. The undescended testis in adult life. Br J Urol. 1985; 57: 181-184. doi: 10.1111/j.1464- 410X.1985.tb06417.x

Farrer J, Walker J, Rajfer J. Management of the postpubertal cryptorchid testis: A statistical review. J Urol. 1985; 134: 1071-1076. doi: 10.1016/S0022-5347(17)47632-4

Swerdlow AJ, Wood KH, Smith PG. A case-control study of the aetiology of cryptorchidism. J Epidemiol Community Health. 1983; 37: 238-244. doi: 10.1136/jech.37.3.238

Barthold JS, Gonzalez R. The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. J Urol. 2003; 170: 2396-2401. doi: 10.1097/01.ju.0000095793.04232.d8

Boisen KA, Kaleva M, Main KM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004; 363: 1264-1269. doi: 10.1097/01. ju.0000095793.04232.d8

Jones ME, Swerdlow AJ, Griffith M, Goldacre MJ. Prenatal risk factors for cryptorchidism: A record linkage study. Paediatr Perinat Epidemiol. 1998; 12: 383-396. doi: 10.1046/j.1365-3016. 1998.00144.x

Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect. 1999; 107: 297-302.

Preiksa RT, Zilaitiene B, Matulevicius V, et al. Higher than expected prevalence of congenital cryptorchidism in Lithuania: A study of 1204 boys at birth and 1-year follow-up. Hum Reprod. 2005; 20: 1928-1932. doi: 10.1093/humrep/deh887

Hutson JM, Balic A, Nation T, Southwell B. Cryptorchidism. Semin Pediatr Surg. 2010; 19: 215-224. doi: 10.1053/j. sempedsurg.2010.04.001

Hezmall HP, Lipshultz LI. Cryptorchidism and infertility. Urol 15 Jones JA, et al Clin North Am. 1982; 9: 361-369.

Hadziselimovic F. Hormonal regulation of testicular descent and maldescent. In: Khoury Kuss S, Murphy R, et al, eds. Testicular Cancer. New York, USA: Liss; 1985.

Chan SL, Cunningham GR, Lipshultz LI. Testicular and post-testicular causes of male infertility. In: White RD, ed. Aspects of Male Infertility. Baltimore, MD, USA: Williams and Wilkins; 1982.

Halme A, Kellokumpo-Lehtinen P, Teppo L. Morphology of testicular germ-cell tumours in treated and untreated cryptorchidism. Br J Urol. 1989; 64: 78-83. doi: 10.1111/j.1464- 410X.1989.tb05527.x

Gilbert JB. Studies in malignant testis tumors. J Urol. 1941; 46: 740-747.

Giwercman A, Grindsted J, Hansen B, et al. Testicular cancer risk in boys with maldescended testis: A cohort study. J Urol. 1987; 138: 1214-1216. doi: 10.1016/S0022-5347(17)43553-1

Fram RJ, Garnick MB, Retik A. The spectrum of genitourinary abnormalities in patients with cryptorchidism, with emphasis on testicular carcinoma. Cancer. 1982; 50: 2243-2245. doi: 10.1002/1097-0142(19821115)50:10<2243::AID-CNCR2 820501045>3.0.CO;2-4

Dinner M, Spitz L. The relationship of testicular tumours to maldescent. S Afr Med J. 1974; 48: 45-46.

Fonger JD, Filler RM, Rider WD, et al. Testicular tumours in maldescended testes. Can J Surgery. 1981; 24: 353-355.

Gerhring G, Rodriguez F, Woodhead D. Malignant degeneration of cryptorchid testes following orchiopexy. J Urol. 1974; 112: 354- 356. doi: 10.1016/S0022-5347(17)59729-3

Morrison AS. Cryptorchidism, hernia, and cancer of the testis. J Natl Cancer Inst. 1976; 56: 731-733. doi: 10.1093/jnci/56.4.731

Henderson BE, Benton B, Jing J, et al. Risk factors for cancer of the testis in young men. Int J Cancer. 1979; 23: 598-602. doi: 10.1002/ijc.2910230503

Schottenfeld D, Warshauer ME, Sherlock S, et al. The epidemiology of testicular cancer in young adults. Am J Epidemiol. 1980; 112: 232-246. doi: 10.1093/oxfordjournals.aje.a112989

Strader C, Weiss N, Daling J, et al. Cryptorchism, orchiopexy, and the risk of testicular cancer. Am J Epidemiol. 1988; 127: 1013- 1018.

Mazanec K, Vorechovsky I. Carcinoma in situ in testicular biopsies. Int Urol Nephrol. 1989; 6: 635-642. doi: 10.1007/ BF02559621

Mannuel HD, Mitikiri N, Khan M, Hussain A. Testicular germ Retrospective Study | Volume 2 | Number 1| cell tumors: Biology and clinical update. Curr Opin Oncol. 2012; 24(3): 266-271. doi: 10.1097/CCO.0b013e32835167fc

Marx GF, Mateo CV, Orkin LR. Computer analysis of postanesthetic deaths. Anesthesiology. 1973; 39: 54.

Giwercman A, Bruun E, Frimodt-Moller C, et al. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol. 1989; 142: 998-1002. doi: 10.1016/S0022-5347(17)38967-X

Thorup J, Mclachlan R, Cortes D, et al. What is new in cryptorchidism and hypospadias – a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg. 2010; 45: 2074-2086. doi: 10.1016/j.jpedsurg.2010.07.030

Waterhouse J, Muir C, Correa P, et al. Cancer incidence in five continents. Lyon, International Agency for Cancer Research, 3: 1976.

Dieckmann K, Becker T, Jonas, et al. Inheritance and testicular cancer. Oncology. 1987; 44: 367-377. doi: 10.1159/000226513

Diekmann K, Boeckmann W, Brosig W, et al. Bilater-al testicular germ cell tumors: Report of nine cases and re-view of the literature. Cancer. 1986; 57: 1254-1258. doi: 10.1002/1097-0142(19860315)57:6<1254::AIDCNCR282057063 2>3.0.CO;2-2

Hayes HM, Pendergrass TW. Canine testicular tumors: Epidemiologic features of 410 dogs. Int J Cancer. 1976; 18: 482- 487. doi: 10.1002/ijc.2910180413

Batata M, Whitmore WJ, Chu F, et al. Cryptorchidism and testicular cancer. J Urol. 1980; 124: 382-388. doi: 10.1016/S0022- 5347(17)55458-0

MacKay EN, Sellers AH. A statistical review of malignant testicular tumours based on the experience of the Ontario Cancer Foundation Clinics. 1938-1961. Canad Med Assoc J. 1966; 94: 889.

Herman JG, Hawkins NV, Rider WD. Cross-canada testis Audit Group. Cryptorchidism and non-seminomatous testis cancer. Int J Androl. 1981; 4(Suppl 4): 123. doi: 10.1111/j.1365-2605.1981. tb00662.x

Debre B, Gauther F, Steg A. Tumors of the cryptorchid or previously cryptorchid testis. Ped Adolesc Endocr. 1979; 6: 224.

Pottern L, Brown L, Hoover R, et al. Testicular cancer risk among young men: Role of cryptorchidism and inguinal hernia. JNCL. 1985; 71: 377-381. doi: 10.1093/jnci/74.2.377

Pike M, Chilvers C, Peckham M. Effect of age at orchidopexy on risk of testicular cancer. Lancet. 1986; 1246-1248. doi: 10.1016/ S0140-6736(86)91389-9

Hack WW, Sijstermans K, Van Der Voort-Doedens LM. Retrospective Study | Volume 2 | Number 1| Jones JA, et al Correction of cryptorchidism and testicular cancer. N Engl J Med. 2007; 357: 825-827. doi: 10.1056/NEJMc071510

Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007; 356: 1835. doi: 10.1056/NEJMoa067588

Ferguson L, Agoulnik AI. Testicular cancer and cryptorchi-dism Front Endocrinol (Lausanne). 2013; 4: 32. doi: 10.3389/fen-do.2013.00032

Skakkebaek NE, Berthelson JG, Giwercman A, Müller J. Car-cinoma-in-situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocy-toma. Int J Androl. 1987; 10: 19-28. doi: 10.1111/j.1365-2605.1987. tb00161.x

Visfeldt J, Giwercman A, Skakkebaek NE. Management of the undescended testis in relation to the development of cancer. J Surge Oncol. 1992; 17: 219-223. doi: 10.1002/jso.2930170304

Muller J, Skakkebaek NE, Nielsen OH, et al. Cryptorchidism and testis cancer. Cancer. 1984; 54: 629-634.

Miniberg DT, Rodger JC, Bedford JM, et al. Ultrastructural evidence of the onset of testicular pathological conditions in the cryptorchid testis within the first year of life. J Urol. 1982; 128: 782- 784. doi: 10.1016/S0022-5347(17)53187-0

Mengel W, Hienz HA, Sippe WG, et al. Studies on cryptorchi-dism: A comparison of histological findings in the germinal epi-thelium before and after the second year of life. J Pediatr Surg. 1974; 9: 445-450. doi: 10.1016/S0022-3468(74)80003-5

Mancini RA, Rosenberg E, Collen M, et al. Cryptorchid and scrotal human testes: I. Cytological, cytochemical and quantitative studies. J Clin Endocrinol Metab. 1965; 25: 927-937. doi: 10.1210/ jcem-25-7-927

Muffly K, Mcwhorter C, Bartone F, Gardner PJ. The absence of premalignant change in the cryptorchid testis before adulthood. J Urol. 1984; 131: 523-525. doi: 10.1016/S0022-5347(17)50478-4

Giwercman A, Berthelsen JG, Muller J, et al. Screening for carcinoma-in-situ of the testis. Int J Androl. 1987; 10: 173-180. doi: 10.1111/j.1365-2605.1987.tb00180.x

Pederson KV, Boisen P, Zetterlund GC. Experience of screening for carcinoma in-situ of the testis amoung young men with surgically corrected maldescended testes. Int J Androl. 1987; 10: 181-185. doi: 10.1111/j.1365-2605.1987.tb00181.x

Jørgensen N, Rajpert-De Meyts E, Graem N, et al. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest. 1995; 72(2): 223-231.

Cortes D, Thorup J, Frisch M, et al. Examination for intracellular germ cell neoplasia at operation for undescended testis in boys. J Urol. 1994; 151: 722-725. doi: 10.1016/S0022-5347(17)35071-1

Cortes D, Thorup JM, Lenz K, Beck BL, Nielsen OH. Laparoscopy in 100 consecutive patients with 128 impalpable testes. Br J Urol. 1995; 75: 281-287. doi: 10.1111/j.1464-410X.1995. tb07338.x

Moore CR, Quick WJ. The scrotum as a temperature regulator for the testes. Am J Physiol. 1924; 68: 70-79. doi: 10.1152/ ajplegacy.1924.68.1.70

Moore CR. Experiments on the sheep testis-cryptorchidism, vasectomy and scrotal insulation. Am J Physiol. 1924; 67: 595-607. doi: 10.1152/ajplegacy.1924.67.3.595

Moore CR. Experimental studies on the male reproductive system. J Urol. 1951; 65: 497-506. doi: 10.1016/S0022- 5347(17)68511-2

Sadi A. Experimental cryptorchidism in rats and its influence on the spermatogenic function. Urol Int. 1957; 5: 232-252. doi: 10.1159/000277316

Nelson WO. Mammalian spermatogenesis: Effect of experi-mental cryptorchidism in the rat and non-descent of the testis in man [In Japanese]. Rec Prog Horm Res. 1951; 6: 29-62.

Pinart E, Bonet S, Briz MD, et al. Morphologic and his-tochemical study of blood capillaries in boar testes: Ef-fects of abdominal cryptorchidism. Teratology. 2001; 63(1): 42-51. doi: 10.1002/1096-9926(200101)63:1<42::AID-TERA1007>3.0.CO;2-K

Forman D, Jones WG, Ward AM, et al. Testicular tumours- the maternal effect. 1985; 109-113.

Gill WB, Schumacher GFB, Bibbo M, Strauss FH., III, Schoen-berg HW. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol. 1979; 122. doi: 10.1016/S0022-5347(17)56240-0

Anderson KC, Li FP, Marchetto DJ. Dizygotic twinning, cryptorchidism, and seminoma in a sibship. Cancer. 1984; 53: 374-376. doi: 10.1002/1097-0142(19840115)53:2<374::AID-CNCR2820530234>3.0.CO;2-B

Sohval AR. Testicular dysgenesis in relation to neoplasm of the testicle. J Urol. 1956; 75: 285-291. doi: 10.1016/S0022- 5347(17)66809-5

Doll DC, Kandzari S, Jenkins JJ, III, et al. Seminoma in a 12- year-old male with 46 xy/45 xo karyotype. Cancer. 1978; 42: 1823-1825. doi: 10.1002/1097-0142(197810)42:4<1823::AID-CNCR2820420421>3.0.CO;2-8

Smolarek TA, Blough RI, Foster RS, et al. Identification of multiple chromosome 12 abnormalities in human testicular germ cell tumors by two-color fluorescence in situ hybridization (FISH). 17 Jones JA, et al Genes Chromosomes Cancer. 1995; 14(4): 252-258. doi: 10.1002/ gcc.2870140403

Smolarek TA, Blough RI, Foster RS, et al. Cytogenetic analy-ses of 85 testicular germ cell tumors: Comparison of postchemo-therapy and untreated tumors. Cancer Genet Cytogenet. 1999; 108(1): 57-69. doi: 10.1016/S0165-4608(98)00113-7

Strohmeyer T. Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors. World J Urol. 1994; 12(2): 74-78. doi: 10.1007/BF00184240

Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001; 16: 972- 978. doi: 10.1093/humrep/16.5.972

Martin D. Germinal cell tumors of the testis after orchiopexy. J Urol. 1979; 121: 422-424. doi: 10.1016/S0022-5347(17)56808-1

Brendler H. Cryptorchidism and Cancer. Testicular Cancer. 1985; 203: 189-196.

Johnson DE, Woodhead DM, Pohl DR, et al. Cryptorchidism and testicular tumorigenesis. Surgery. 1968; 63: 919-922.

Gofrit O, Pode D. Treatment for cryptorchidism: At or after puberty? Harefuah. 1993; 124(8): 472-474.

Sumner WA. Malignant tumor of testis occurring 29 years after orchiopexy. J Urol. 1959; 81: 150-152. doi: 10.1016/S0022- 5347(17)65981-0

Giwercman A, Berthelsen JG, Muller J, Skakkebaek NE. Carcinoma-in-situ of the cryptorchid testis. Testicular Cancer. 1985; 177-188.

Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010; 42: 604-607. doi: 10.1038/ng.607

Kanetsky PA, Mitra N, Vardhanabhuti S, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet. 2009; 41: 811-815. doi: 10.1038/ng.393

Altman BL, Malament M. Carcinoma of the testis following orchiopexy. J Urol. 1967; 97: 498-504. doi: 10.1016/S0022- 5347(17)63068-4

Campbell HE. The incidence of malignant growth of the undescended testicle: A reply and re-evaluation. J Urol. 1959; 81: 663-668. doi: 10.1016/S0022-5347(17)66088-9

Donohue JP. Treatment of local regional disease: Germ cell tumors. In: Ackermann Diehl R, Heidelberg V, eds. Recent Results in Cancer Research. Heidelberg, Germany: Springer-Verlag Berlin; 1993: 217-225. Retrospective Study | Volume 2 | Number 1|

Donohue J, Thornhill J, Foster R, et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer. J Urol. 1993; 149: 237-243. doi: 10.1016/S0022-5347(17)36046-9

Hayakawa M, Mukai K, Nagakura K, et al. A case of simultaneous bilateral germ cell tumors arising from cryptorchid testes. J Urol. 1986; 136: 470-472. doi: 10.1016/S0022-5347(17)44913-5

Hinman FJ. Optimum time for orchiopexy in cryptorchidism. Fertil Steril. 1955; 6: 206-214. doi: 10.1016/S0015-0282(16)31981-1 .

Krabbe S, Berthelsen J, Volsted P, et al. High incidence of undetected neoplasia in maldescended testes. Lancet. 1979; 999- 1000. doi: 10.1016/S0140-6736(79)92754-5

Kulkarni R, Netzloff ML, Texera C. Familial cryptorchidism and testicular tumors in non-twin brothers. Ann Clin Lab Sci. 1983; 13: 327-331.

Kratzik C, Aiginger P, Kuber W, et al. Risk factors for bilateral testicular germ cell tumors. Cancer. 1991; 68: 916-921. doi: 10.1002/1097-0142(19910815)68:4<916::AID-CNCR2820680 440>3.0.CO;2-R

Shanahan M, Ramus N, White H. Intra-abdominal seminoma after ‘orchidectomy’. Br J Surg. 1982; 69: 705. doi: 10.1002/ bjs.1800691206 Submit your article to this journal | https://openventio.org/submit-manuscript/ Retrospective Study | Volume 2 | Number 1| Jones JA, et al

Waxman M. Malignant germ cell tumor in situ in a cryptorchid testis. Cancer. 1976; 38: 1452-1456. doi: 10.1002/1097-0142(197 609)38:3<1452::AID-CNCR2820380353>3.0.CO;2-C

Berthelsen J, Skakkebaek NE, Mogensen P, Sorensen BL. Incidence of carcinoma in situ of germ cells in contralateral testis for men with testicular tumours. Br Med J. 1979; 2: 363-364. doi: 10.1136/bmj.2.6186.363

Berthelsen JG, Skakkebaek NE, von der Masse H, et al. Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br Med J. 1982; 285: 1683- 1686. doi: 10.1136/bmj.285.6356.1683

Coldman A, Elwood J, Gallagher R. Sports activities and risk of testicular cancer. Br J Cancer. 1982; 46: 749-756. doi: 10.1038/ bjc.1982.267

Czeizel A, Erodi E, Toth J. An epidemiological study on undescended testis. J Urol. 1981; 126: 524-527. doi: 10.1016/ S0022-5347(17)54609-1

Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, CO, USA: Publishing Sciences Group; 1977.

Beard CM, Melton LJ., III, O’Fallon WM, Noller KL, Benson RC. Crypthorchidism and maternal estrogen exposure. Amer J Epidemiol. 1984; 120: 707.

Published

2018-04-11

How to Cite

Jeffrey A. Jones, Christopher W. Hobaugh, Daniel B. Salvas, Richard M. Bennett, Guilherme Godoy, & John P. Donohue. (2018). Outcomes in Patients with Testicular Maldescent and Germ Cell Neoplasia: A Retrospective Assessment and Review of the Literature. Urology and Andrology , 2(1), 8–18. https://doi.org/10.17140/UAOJ-2-113